Genenta's CEO to present at the U.S. Senate meeting on "Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective" [Financial Post (Toronto, Ontario, Canada)]
Genenta’s CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective”
Genenta Science S.p.A.'s (NASDAQ:GNTA) market cap rose US$46m last week; individual investors who hold 55% profited and so did insiders [Yahoo! Finance]
Genenta Science S.p.A. (NASDAQ: GNTA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.
Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer [Financial Post (Toronto, Ontario, Canada)]